MyFinsight
Home
About
Contact
cldx: the income statement
Download
Download image
Comprehensive loss
-$66,618,000
(-72.53%↓ Y/Y)
Unrealized gain on
marketable securities
$426,000
(-87.86%↓ Y/Y)
Net loss
-$67,044,000
Investment and other
income, net
$6,573,000
Operating loss
-$73,617,000
Total operating
expenses
$73,617,000
General and
administrative
$10,686,000
Research and development
$62,931,000
Back
Back
Income Statement
source: myfinsight.com
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)